TRANSRECTAL PROSTATE THERAPY ROBOT IN CLOSED MRI SCANNER

封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人

基本信息

  • 批准号:
    7360393
  • 负责人:
  • 金额:
    $ 2.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2006
  • 资助国家:
    美国
  • 起止时间:
    2006-08-01 至 2007-07-31
  • 项目状态:
    已结题

项目摘要

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Numerous studies have demonstrated the efficacy of needle-based therapy and biopsy procedures in the management of prostate cancer. Despite all advances in clinical and biophysical methodologies, however, precise anatomy-guided needle placement and real-time monitoring of the actual therapeutic process are still unsolved problems. Magnetic resonance imaging (MRI) has been found to be an ideal imaging modality for guiding and monitoring prostatic interventions, due to its high specificity to soft tissue abnormalities, real-time capability in monitoring needle placement and induced physiological changes, and its ability to show concurrent metabolic activity if combined wil:h spectroscopy. At the same time, however, closed high-field MRI historically has been the most unavailable imaging modality for guiding minimally invasive interventions. The scanner's high magnetic field and extremely confined physical space present a formidable engineering challenge, and "conventional" difficulties such as needle deflection, tissue deformation, and target motion also add to the problem. Our ultimate goal is to provide a technology platform for precise transrectal needle placement into the prostate for diagnostic, analytical, and therapeutic purposes; inside a conventional closed MRI scanner, under active real-time MRI guidance and monitoring. In prior work, we have developed a prototype of such an integrated system and proved the feasibility of our approach in a variety of diagnostic and therapeutic applications, invivo on canines. In response to this RFA, we propose to develop a more advanced system that is suitable for a variety of applications on human patients.
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。许多研究已经证明了基于针的治疗和活检程序在前列腺癌管理中的有效性。然而,尽管在临床和生物物理方法学方面取得了所有进展,但精确的解剖学引导的针放置和实际治疗过程的实时监测仍然是未解决的问题。磁共振成像(MRI)已被发现是一种理想的成像模式,用于指导和监测前列腺干预,由于其对软组织异常的高特异性,实时监测针的放置和诱导的生理变化的能力,以及如果结合wil:h光谱显示并发代谢活动的能力。然而,与此同时,封闭式高场MRI在历史上一直是指导微创干预的最不可用的成像模式。扫描仪的高磁场和极其有限的物理空间提出了一个艰巨的工程挑战,和“传统”的困难,如针偏转,组织变形,和目标运动也增加了问题。 我们的最终目标是提供一个技术平台,用于在传统的封闭式MRI扫描仪内,在主动实时MRI引导和监测下,将经直肠穿刺针精确置入前列腺,用于诊断、分析和治疗目的。在以前的工作中,我们已经开发了这样一个集成系统的原型,并证明了我们的方法在各种诊断和治疗应用中的可行性,invivo犬。针对这种RFA,我们建议开发一种更先进的系统,适用于人类患者的各种应用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

GABOR FICHTINGER其他文献

GABOR FICHTINGER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('GABOR FICHTINGER', 18)}}的其他基金

Functional imaging and genetics in schizophrenia: search for endophenotypes
精神分裂症的功能成像和遗传学:寻找内表型
  • 批准号:
    7669321
  • 财政年份:
    2008
  • 资助金额:
    $ 2.02万
  • 项目类别:
TRANSRECTAL PROSTATE THERAPY ROBOT IN CLOSED MRI SCANNER
封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人
  • 批准号:
    7563683
  • 财政年份:
    2007
  • 资助金额:
    $ 2.02万
  • 项目类别:
TRANSRECTAL PROSTATE THERAPY ROBOT IN CLOSED MRI SCANNER
封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人
  • 批准号:
    7166950
  • 财政年份:
    2005
  • 资助金额:
    $ 2.02万
  • 项目类别:
Transrectal Ultrasound Ablation Of The Prostate
经直肠前列腺超声消融术
  • 批准号:
    6840292
  • 财政年份:
    2004
  • 资助金额:
    $ 2.02万
  • 项目类别:
Transrectal Prostate Therapy Robot in Closed MRI Scanner
封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人
  • 批准号:
    6802031
  • 财政年份:
    2003
  • 资助金额:
    $ 2.02万
  • 项目类别:
Transrectal Prostate Therapy Robot in Closed MRI Scanner
封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人
  • 批准号:
    7104929
  • 财政年份:
    2003
  • 资助金额:
    $ 2.02万
  • 项目类别:
Transrectal Prostate Therapy Robot in Closed MRI Scanner
封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人
  • 批准号:
    6930960
  • 财政年份:
    2003
  • 资助金额:
    $ 2.02万
  • 项目类别:
Transrectal Prostate Therapy Robot in Closed MRI Scanner
封闭式 MRI 扫描仪中的经直肠前列腺治疗机器人
  • 批准号:
    6735900
  • 财政年份:
    2003
  • 资助金额:
    $ 2.02万
  • 项目类别:

相似海外基金

Designing Rational Combinations to Improve CAR T Cell Therapy for Prostate Cancer
设计合理的组合以改善前列腺癌的 CAR T 细胞疗法
  • 批准号:
    10752046
  • 财政年份:
    2024
  • 资助金额:
    $ 2.02万
  • 项目类别:
The role of focal adhesion kinase in therapy resistant prostate tumors
粘着斑激酶在治疗耐药性前列腺肿瘤中的作用
  • 批准号:
    10638034
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
Revisiting Antiangiogenic Therapy to Target Hormone-Sensitive Prostate Cancer Metabolism
重新审视抗血管生成疗法以靶向激素敏感的前列腺癌代谢
  • 批准号:
    10671250
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
Project 2: Androgen deprivation as an immune modulating therapy in combination with targeted immunotherapy of prostate cancer
项目2:雄激素剥夺作为免疫调节疗法与前列腺癌靶向免疫疗法相结合
  • 批准号:
    10555401
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
Primary prostate cancer cells as novel models for patient therapy prediction
原发性前列腺癌细胞作为患者治疗预测的新模型
  • 批准号:
    477987
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
    Operating Grants
Prostate Specific Anti-androgen Therapy for Localized Prostate Cancer
前列腺特异性抗雄激素疗法治疗局限性前列腺癌
  • 批准号:
    10760194
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
COP1 REGULATION OF AR SIGNALING AND PROSTATE CANCER GROWTH AND THERAPY RESISTANCE
COP1 对 AR 信号传导和前列腺癌生长及治疗耐药的监管
  • 批准号:
    10660204
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
"Novel Mouse Models for Quantitative Understanding of Baseline and Therapy-Driven Evolution of Prostate Cancer Metastasis"
“用于定量了解前列腺癌转移的基线和治疗驱动演变的新型小鼠模型”
  • 批准号:
    10660349
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
Therapy-induced cognitive impairment in a rat model of prostate cancer
前列腺癌大鼠模型中治疗引起的认知障碍
  • 批准号:
    10766874
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
Regulation of RNA Decapping and Degradation: A novel approach to prostate cancer therapy
RNA 脱帽和降解的调控:前列腺癌治疗的新方法
  • 批准号:
    10758110
  • 财政年份:
    2023
  • 资助金额:
    $ 2.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了